These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7159901)

  • 1. Release of norepinephrine and dopamine from brain vesicular preparations: effects of adenosine analogues.
    Ebstein RP; Daly JW
    Cell Mol Neurobiol; 1982 Sep; 2(3):193-204. PubMed ID: 7159901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of norepinephrine and dopamine from brain vesicular preparations: effects of calcium antagonists.
    Ebstein RP; Daly JW
    Cell Mol Neurobiol; 1982 Sep; 2(3):205-13. PubMed ID: 7159902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adenosine on norepinephrine and acetylcholine release from guinea pig right atrium: role of A1-receptors.
    Nakatsuka H; Nagano O; Földes FF; Nagashima H; Vizi ES
    Neurochem Int; 1995; 27(4-5):345-53. PubMed ID: 8845735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effects of adenosine and baclofen.
    Burke SP; Nadler JV
    J Neurochem; 1988 Nov; 51(5):1541-51. PubMed ID: 2902197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
    Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF; Lu GH; Pugsley TA
    Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of high affinity and low affinity adenosine binding sites in human cerebral cortex.
    John D; Fox IH
    Adv Exp Med Biol; 1986; 195 Pt B():57-69. PubMed ID: 2429512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of norepinephrine from brain vesicular preparations: effects of an adenylate cyclase activator, forskolin, and a phosphodiesterase inhibitor.
    Ebstein RP; Seamon K; Creveling CR; Daly JW
    Cell Mol Neurobiol; 1982 Sep; 2(3):179-92. PubMed ID: 6891616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
    J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine receptor mediated inhibition of noradrenaline release from slices of the rat hippocampus.
    Jonzon B; Fredholm BB
    Life Sci; 1984 Nov; 35(19):1971-9. PubMed ID: 6092809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
    Murayama T; Itahashi Y; Nomura Y
    J Neurochem; 1990 Nov; 55(5):1631-8. PubMed ID: 2145396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine receptors in rat brain membranes: characterization of high affinity binding of [3H]-2-chloroadenosine.
    Wu PH; Phillis JW
    Int J Biochem; 1982; 14(5):399-404. PubMed ID: 6282666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release.
    Jin S; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):48-56. PubMed ID: 9007842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of high-affinity and low-affinity adenosine binding sites in human cerebral cortex.
    John D; Fox IH
    J Lab Clin Med; 1985 Oct; 106(4):401-7. PubMed ID: 2995523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction.
    Ribeiro JA; Sebastião AM
    Br J Pharmacol; 1985 Apr; 84(4):911-8. PubMed ID: 2988684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
    Cunha RA; Constantino MD; Ribeiro JA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release.
    Zetterström T; Fillenz M
    Eur J Pharmacol; 1990 May; 180(1):137-43. PubMed ID: 2364998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.